Related Experiment Video

Updated: Jun 6, 2026

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
10:49

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Published on: September 18, 2013

Identification of new possible targets for leukemia treatment by kinase activity profiling

Arja Ter Elst1, Sander H Diks, Kim R Kampen

  • 1Department of Pediatric Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.

Leukemia & Lymphoma
|December 8, 2010
PubMed

Insights

High-throughput kinase profiling reveals common active targets in acute leukemia, aiding the discovery of new therapeutic strategies for this complex disease.

Area of Science:

  • Oncology
  • Biochemistry
  • Molecular Biology

Background:

  • The biology of acute leukemia is not well understood, complicating the identification of new therapeutic targets.
  • High-throughput techniques offer a promising approach to elucidate disease biology and assess therapeutic targets.

Purpose of the Study:

  • To identify comprehensive tyrosine kinase activity profiles in leukemia samples.
  • To discover novel therapeutic targets and understand leukemia pathogenesis through kinase activity profiling.

Main Methods:

  • Utilized the PamChip® kinase activity profiling system to analyze tyrosine kinase activity in leukemia samples.
  • Constructed a provisional signal transduction scheme based on active peptides.
  • Selected a specific inhibitor for leukemic blast cell survival assays.

Main Results:

  • Identified comprehensive tyrosine kinase activity profiles across different leukemia types.
  • Found that 31% of detected peptides were active in all three leukemia groups.
  • Observed activity in platelet-derived growth factor receptor (PDGFR), neurotrophic tyrosine kinase receptors (NTRK1, NTRK2), and macrophage stimulating 1 receptor (MST1R).
  • Demonstrated a dose-dependent decrease in leukemic blast cell survival using a selected inhibitor.

Conclusions:

  • Kinase activity profiling is a feasible method for analyzing leukemic samples.
  • This approach provides novel insights into leukemia pathogenesis and can rapidly identify potential drug targets.
  • The findings support the use of kinase profiling for discovering new therapeutic strategies in acute leukemia.

More Related Videos

A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors12:40

A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors

Published on: December 7, 2014

Characterization at the Molecular Level using Robust Biochemical Approaches of a New Kinase Protein11:23

Characterization at the Molecular Level using Robust Biochemical Approaches of a New Kinase Protein

Published on: June 30, 2019

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...